Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712737 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'The Cancer Outlook to' returned 914 results - Page 1 of 46

 FEATURED RESULTS
Cancer Diagnostic Testing World Markets

Drug Delivery in Cancer - Technologies, Markets and Companies

Antibody Drug Target Atlas in Oncology

Aurora Kinase inhibitors - The dawn of a new approach to cancer

Cancer Chemotherapy: Basic Science to the Clinic


  Sort by   
  Sorted by Rank Top-Bottom

The Cancer Market Outlook to 2016  
Business Insights, June 2011, Pages: 164
- Takeda The Cancer Market Outlook to 2016


Lung Cancer Therapeutics Market Outlook and Pipeline Analysis  
Arrowhead Publishers, Nov 2009
SCLC - AstraZeneca - Eli-Lilly - GlaxoSmithKline - OSI Pharmaceuticals - Roche - Sanofi-Aventis Lung Cancer Therapeutics Market Outlook and Pipeline Analysis


Dealmaking and Industry Outlook: Targeted Cancer Therapies  
Decision Resources, Inc., Dec 2009, Pages: 38
Angeles - University Hospital of Parma - Veridex - Wyeth - Yakult Honsha Dealmaking and Industry Outlook: Targeted Cancer Therapies


Global Lung Cancer Surgery Market (Devices & Treatment Outlook) – Trends & Challenges (2010 – 2015)  
Markets and Markets, July 2011, Pages: 228
Strategies In Lung Cancer Surgery Market (January 2008 – March 2011) Global Lung Cancer Surgery Market (Devices & Treatment Outlook) – Trends & Challenges (2010 – 2015)


The Cancer Market Outlook to 2010  
Business Insights, Nov 2005
and pharmaceutical companies. The new report 'The Cancer Market Outlook to 2010' provides detailed analysis on 9 key indications in the cancer market, identifying growth brands, leading companies and epidemiology


Dealmaking and Industry Outlook: Therapeutic Antibodies and Vaccines for Cancer  
Decision Resources, Inc., March 2009, Pages: 49
Dealmaking and Industry Outlook: Therapeutic Antibodies and Vaccines for Cancer


U.S. Colorectal Cancer Markets - Patient Outlook  
Frost & Sullivan, Dec 2006, Pages: 36
This research service provides the patient outlook and forecast for colorectal cancer in the U.S. from 2003-2013. The patient population is discussed in terms of staging and line of therapy


Approval Outlook for Avastin® as a Breast Cancer Treatment: A Survey of Fifty Oncologists (Survey)  
Panel Intelligence, LLC, Feb 2008
cancer patients - Genentech Approval Outlook for Avastin® as a Breast Cancer Treatment: A Survey of Fifty Oncologists (Survey)


Competitive Outlook on Non-Antibody Based Cancer Vaccines  
Bioseeker, Aug 2006, Pages: 138
Cancer Vaccines in Development for Colorectal Cancer Table 14: List of Phase I to Phase III Cancer Vaccines in Development for Cervical Cancer Competitive Outlook on Non-Antibody Based Cancer Vaccines


Competitive Outlook on Lung Cancer Drug Development - The Missing Handbook to New Product Planning and Portfolio Planning  
Bioseeker, Aug 2009, Pages: 751
Pharmaceutical - Wilex - Wyeth - Xerion - Xoma - Yakult Honsha - YM BioSciences - Zivena Competitive Outlook on Lung Cancer Drug Development - The Missing Handbook to New Product Planning and Portfolio


Outlook for Cancer Vaccine Development  
Decision Resources, Inc., May 2005, Pages: 13
-stage development. We identify challenges and opportunities facing cancer vaccines in view of their short history and discuss the outlook for the vaccine market Business Implications


The 2011-2016 Outlook for Cancer Therapies in India  
ICON Group International, Jan 2011, Pages: 319
, the U.S. Industrial Outlook, and the World Bank). Depending on original data sources used, the definition of “cancer therapies” is established. In the case of this report, the data were reported


The 2011-2016 Outlook for Cancer Therapies in Japan  
ICON Group International, Jan 2011, Pages: 141
Provisions The 2011-2016 Outlook for Cancer Therapies in Japan


The 2011-2016 World Outlook for Bladder Cancer Therapeutics  
ICON Group International, Jan 2011, Pages: 195
Outlook for Bladder Cancer Therapeutics


The 2011-2016 World Outlook for Cancer Therapies  
ICON Group International, Jan 2011, Pages: 192
. User Agreement Provisions The 2011-2016 World Outlook for Cancer Therapies


The 2011-2016 World Outlook for Liver Cancer Drugs  
ICON Group International, Jan 2011, Pages: 197
, Inc. User Agreement Provisions The 2011-2016 World Outlook for Liver Cancer Drugs


The 2011-2016 World Outlook for Pancreatic Cancer Drugs  
ICON Group International, Jan 2011, Pages: 198
, Inc. User Agreement Provisions The 2011-2016 World Outlook for Pancreatic Cancer Drugs


The 2011-2016 World Outlook for Prostate Cancer Therapeutics  
ICON Group International, Jan 2011, Pages: 198
, Inc. User Agreement Provisions The 2011-2016 World Outlook for Prostate Cancer Therapeutics


The 2011-2016 Outlook for Cancer Therapy Pharmaceuticals in Greater China  
ICON Group International, Jan 2011, Pages: 142
Financial Services, the U.S. Industrial Outlook, and the World Bank). Depending on original data sources used, the definition of “cancer therapy pharmaceuticals” is established. In the case of this report


The 2011-2016 Outlook for Cancer Therapy Pharmaceuticals in India  
ICON Group International, Feb 2011, Pages: 316
Monetary Fund, Euromonitor, Mintel, Thomson Financial Services, the U.S. Industrial Outlook, and the World Bank). Depending on original data sources used, the definition of “cancer therapy pharmaceuticals


Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds